Tag: BRAF-mutated melanoma

#VisualAbstract: Pyrotinib plus capecitabine improves progression-free survival in HER2⁺ metastatic breast cancer

#VisualAbstract: Circulating tumor DNA levels may predict treatment response in patients with advanced melanoma

byTeddy Guo

March 11, 2021

Click to read the study in The Lancet Oncology.

#VisualAbstract: Endocrine therapy plus oral S-1 improves invasive disease-free survival in patients with ER⁺ breast cancer

#VisualAbstract: BRAF/MEK inhibitor therapy may be associated with risk of uveitis in patients with advanced melanoma

byTeddy Guo

February 11, 2021

Click to read the study in the European Journal of Cancer.

#VisualAbstract: Durvalumab, trametinib, and dabrafenib triplet therapy may provide robust immunogenicity in patients with BRAF-mutated advanced melanoma

byTeddy Guo

January 14, 2021

Click to read the study in Nature Communications

Page 2 of 2 Prev 1 2

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result